Table 2 Comparison of the results of the clinician review and the original and refined PRESTARt tools both by country and overall. Data given as n (%)
UK | Germany | Portugal | Spain | Greece | Total | |
|---|---|---|---|---|---|---|
High risk, clinician | 27 (33.3) | 53 (53.0) | 43 (19.0) | 67 (51.9) | 51 (51.0) | 241 (37.9) |
High risk, original tool | 18 (22.2) | 51 (51.0) | 30 (13.3) | 51 (39.5) | 64 (64.0) | 214 (33.7) |
High risk, refined tool | 26 (32.1) | 63 (63.0) | 69 (30.5) | 116 (89.9) | 69 (69.0) | 343 (53.9) |